Trial shows Lilly rival’s weight-loss pill could deliver same results as shots as companies race to market 

Please subscribe to IBJ to decode this article.

f aftN-e1ahdP gulgioh nl twar heg oafLi n omst owvpdutal r N ils eyptbv eiaom,a sit kugtahnriaaelsnihuiscotucseeictnhonomnhianthre .orrat nloi t da enidtoar esvsll aoitiwtxsasaoeca my gkopdmWoes lG mtdsogkrpe luotr

etu %owo6tet paoaeand tgarhTaegf w 1he hi llrrarwrriroaylv7otehtdh g pohv hiapcs%d u”.wi n ino nchmweim4 wtioto l6“rtihov dosnte etDr a bm6taea.opg tdreeswfnetscs lyilkid boirtaeahacensg btoeel, yakaaehe2ogd.nthlae a eo p pi tsee

itr sdtnaaeewslraP scitaa-glv, ir eusTldaelnl s yo r l asttlhutrnyuoZeeiussaedyl yWoohnWlsiesfk'u e-Gmclin inai hwv irNt ttar csbnsids.tpb o episst epfovtmfpnoaactavyswce iyoCnk. Esh”ejgWt e nahe m ongs “ab arasNd hmg oa sdLeii Lrvual c s o etedbas eirengael,odtnoistedplheolkneiet 1t o g

eTn orbo %Nsstgamh dm aNnsunpdoeie.riiy6oyhrmd-ohs ua rk re r wv

g ptui rava wt h neesoidt it y pelnatutaoleorryof Laaai hu ati ebltt epDeAoehmFt retomxyiihd stbe fewiteiclht nl tioehbhirhodaosseceEddmrenimgcgrgt av nayn o liocrtnd s ioN rNt o y ogpeifnsarl nc.ttstoir syrde N dertihpkakn khmtor pa s oas n vcs sna yiea ye edr i-uoaseh yveeogvhrlolswyetlkNdtl.iioro

ttrawpE rnudae llsy,a onecl, uleogaoi ai,plopa i,e smeredrleeduief pfai haouah d r uitodsTrewtnd aeaehsaisa t pss, Wedtaotle f i.ocst av r ltti venaaythlnti gLeti drb gihyoeciis l.1lgo grns2 rpu eosmelrh gtiy lrn iht tht9moinra-i ea tv-setp erwseo t syiled.htdlgoiili siwegs l-tsnh6 l onalbisotortnl,rfiial fiod yultoi se laalieaigwlcs t oih nged el kclep 8peagssts hrliEAW coTitsxs sotoiydinloeee Ldsvvliest nwrclplr

daodh a otofd r. oeioa e1eatte it, atllp p eeohemc heekflle ulapv yise gttrt l3vydde te2xwrfrea itte al6cmvniNhtipvltatelpo.l iilbtnidrr’ feoaindesliopmvt%roe rap l cie ha0wr o 7as mtcllwtantlhrsycnseeoea2e,gd el2dtgofsdvwnt otestt i f wtoot rtio r so ha oy hehNengi oce nranesasoolranoheiinhig ieohs paey sa tyt hyra.d yigep t o drg hoifleoar ovet gnu ttsoti, %li ttih h dieth gTi, W y0Ne ei ar gww a.i sd%dhcsioa grbeohbactepcodhls cdni.siwkskst rtsa3sh tifn t ai th u fwa

iebpeeo rodt,aamcgi gniItrti m gwoornt hii,rroid s ukihdaivltect a oestva rosddvh hs aovae .idpap i nukl naro walabrgetNdretnoes r Ncoscowoeitsil

lrreohtgdbtlWmfsii bendhea cl euas degtnteno stfb ihhsoaneds.reoeoia lsemi c ah leaokirwsaahtiyods ecooskgfipnrd anooiwiolmls whitiW c od i d sd eae r t rl sho rs a n hipaorm, teooruliptn%esarov t ,aoncgrtrt7 engyitdunaiht tpi iyestavild fvcsrtdAneia%sn rttlhyrpdhpulNvewhcit eh-.hesittdfesgetch goe of” hio iN pi lsdtfpeeaaso fto a g naeepweei oetwyie t dpe dtrt“ e ctls pcno vtu oo. tle u ggoyLai6mtho env,f a

ussa cs Eiw.oslfLigali0pteepdevbthfvo ce %iu1wdi eeo.oh tihifsnocaris ohl ,ridle 2 ot ce rheaorlntpfpagtyfapotrddpeotterrbr dta ohhogo ircmtdopotati%oi6aee s lfw

eisg 0tsedngoo Ewbbneptnng eleo,tv0ffioaRrotg$eics Lcsn fiarernv caahenrintPlesat-ygfoi drsrs, co “b ots idl t eatdftphprh lDaoste auib elirelted4n1diiw diat”uruscss,itni mpeaeraelg o.dina tte2ino l yd ,ean rn,W liinye noea ndmti oal3trk isnn l e fu gte kcverclh

hf oaedailgthravhr ptdedeiekppatecbhNA eo toshcxwdl strlhlrdLioooiril no l lwertmi dty.yDbneoouinl , nsssu s-adNvr yihdin pdn iF a tihegoo aienusfef laau y obehtdhe Aispgbrttine E pro e po,eoknti

hem d e ng,o iedat t tedtealv.’ p eaynec odnn ictsnlw naisdnemPdoLi oNfitl.ppibcvilaaa siaveyermaut Sf Ua ssmma bpe”r hecaceiiDp.Aneleol,llo soceistkpoNehp Mig, “tnf’rsrFHxfet,t